231 related articles for article (PubMed ID: 11650075)
41. Guidelines for addressing ethical and legal issues in Alzheimer disease research: a position paper.
High DM; Whitehouse PJ; Post SG; Berg L
Alzheimer Dis Assoc Disord; 1994; 8(Suppl. 4):66-74. PubMed ID: 11657676
[No Abstract] [Full Text] [Related]
42. How many subjects are required for a study?
McLarty JW; Levine RJ
IRB; 1987; 9(5):1-3. PubMed ID: 11649896
[No Abstract] [Full Text] [Related]
43. The role and responsibility of industry in research.
Lasagna L
Dolentium Hominum; 1987; 4(2nd Yr. 1):56-9. PubMed ID: 11653199
[No Abstract] [Full Text] [Related]
44. Researchers and subpoenas: the troubling precedent of the Selikoff case.
Holder AR
IRB; 1989; 11(6):8-10. PubMed ID: 11650287
[No Abstract] [Full Text] [Related]
45. Minimal risk, administrative firm trials, and informed consent.
O'Neil TJ; Goldberg H; McGough H
IRB; 1992; 14(3):9-10, 12. PubMed ID: 11656139
[No Abstract] [Full Text] [Related]
46. A doctor's drug studies turn into fraud.
Eichenwald K; Kolata G
N Y Times Web; 1999 May; ():A1, A16. PubMed ID: 11647660
[No Abstract] [Full Text] [Related]
47. Exposure to radiation and informed consent.
Massé FX; Miller T
IRB; 1985; 7(4):1-4. PubMed ID: 11650703
[No Abstract] [Full Text] [Related]
48. Research on healthy volunteers: a report of the Royal College of Physicians.
Royal College of Physicians
J R Coll Physicians Lond; 1986 Oct; 20(4):3-17. PubMed ID: 11643937
[No Abstract] [Full Text] [Related]
49. The ethics of research involving radiation.
Veatch RM
IRB; 1982 Jan; 4(1):3-5. PubMed ID: 11650532
[No Abstract] [Full Text] [Related]
50. Testing the implementation of clinical guidelines.
Goldberg HI; McGough H
IRB; 1991; 13(6):1-7. PubMed ID: 11656109
[No Abstract] [Full Text] [Related]
51. Structuring the review of human genetics protocols, Part II: diagnostic and screening studies.
Glass KC; Weijer C; Lemmens T; Palmour RM; Shapiro SH
IRB; 1997; 19(3-4):1-13. PubMed ID: 11656943
[No Abstract] [Full Text] [Related]
52. Informed consent process and document is criticized in court.
Maloney DM
Hum Res Rep; 1994 Dec; 9(12):4-5. PubMed ID: 11654162
[No Abstract] [Full Text] [Related]
53. Rate of refusal to participate in clinical trials.
Shimm DS; Spece RG
IRB; 1992; 14(2):7-9. PubMed ID: 11651246
[No Abstract] [Full Text] [Related]
54. Moore v. Regents of the University of California: expanded disclosure, limited property rights.
Potts J
Northwest Univ Law Rev; 1992; 86(2):453-96. PubMed ID: 11659500
[No Abstract] [Full Text] [Related]
55. Reviewing subject recruitment: new rules from Rockville.
McMahon FG
IRB; 1988; 10(3):6-7. PubMed ID: 11651911
[No Abstract] [Full Text] [Related]
56. The promise that failed.
Brauer R
N Y Times Mag; 1988 Aug; ():35, 46, 48. PubMed ID: 11646200
[No Abstract] [Full Text] [Related]
57. Informed consent in psychiatric research.
Roth LH; Appelbaum PS; Lidz CW; Benson P; Winslade WJ
Rutgers Law Rev; 1987; 39(2-3):425-41. PubMed ID: 11659013
[No Abstract] [Full Text] [Related]
58. Power, advocacy, and informed consent forms.
Smith ML
J Calif Alliance Ment Ill; 1994; 5(1):25-7. PubMed ID: 11653311
[No Abstract] [Full Text] [Related]
59. The expert surrogate system: a role for the Golden Rule in clinical practice.
Mackillop WJ
Humane Med; 1988 Nov; 4(2):89-95. PubMed ID: 11650833
[No Abstract] [Full Text] [Related]
60. Worker notification and institutional review for privately funded research in occupational health and safety.
American Public Health Association
Am J Public Health; 1996 Mar; 86(3):432-3. PubMed ID: 11644772
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
